title: Fatty acids regulate CREBh via transcriptional mechanisms that are dependent on proteasome activity and insulin.
abstract: Excess fatty acids are closely associated with metabolic dysfunction. The deleterious effects of fatty acids relate, in part, to their ability to up-regulate pro-inflammatory cytokines and propagate a state of systemic inflammation. CREBh is a recently identified transcription factor that appears to be required for hepatic synthesis of C-reactive protein. Recent data suggest that fatty acids can up-regulate CREBh, thus establishing a potential molecular link between fatty acids and inflammation. The aim of this study was to examine the nature and mechanisms of fatty acid-mediated regulation of CREBh. H4IIE liver cells were incubated in the absence or presence of varying concentrations (50-500 μM) of albumin-bound, long-chain saturated (palmitate, stearate) or unsaturated (oleate, linoleate) fatty acids (1-16 h). All fatty acids significantly increased CREBh gene expression via transcriptional mechanisms, at concentrations as low as 50 μM. Palmitate- or oleate-mediated up-regulation of CREBh was not inhibited by triacsin C, an inhibitor of long-chain fatty acyl CoA synthetase, or by the PPARα antagonist, MK886. Inhibition of proteasome activity with MG132 or lactacystin, or inclusion of insulin reduced palmitate- and oleate-mediated increases in CREBh mRNA. Finally, we examined fatty acid regulation of CREBh in vivo. Male Wistar rats were exposed to a 4-h pancreatic clamp combined with infusion of saline or a mixed lipid emulsion. CREBh mRNA and protein were significantly increased in rats exposed to the lipid infusion compared to the saline group. Collectively, these results may have important implications for metabolic diseases characterized by excess fatty acids, insulin resistance, and inflammation.
authors.affiliation: Department of Food Science and Human Nutrition, Colorado State University, Fort Collins, CO 80523, USA.
authors.forename: C L
authors.initials: CL
authors.lastname: Gentile
authors.forename: D
authors.initials: D
authors.lastname: Wang
authors.forename: K T
authors.initials: KT
authors.lastname: Pfaffenbach
authors.forename: R
authors.initials: R
authors.lastname: Cox
authors.forename: Y
authors.initials: Y
authors.lastname: Wei
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Pagliassotti
mesh_terms: D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D017362:Cyclic AMP Response Element-Binding Protein / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D017931:DNA Primers; D005227:Fatty Acids / Q000494:pharmacology*; D007328:Insulin / Q000378:metabolism*; D007333:Insulin Resistance; D008297:Male; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017208:Rats, Wistar; D014158:Transcription, Genetic / Q000187:drug effects*
chemical_list: C000607973:Creb3l3 protein, rat; D017362:Cyclic AMP Response Element-Binding Protein; D017931:DNA Primers; D005227:Fatty Acids; D007328:Insulin; D012333:RNA, Messenger; D046988:Proteasome Endopeptidase Complex